Vera Therapeutics, Inc. (VERA) Free cash flow 2020–2025
Vera Therapeutics, Inc. (VERA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$241.7MFY2025 · since FY2020: -$34.9M → -$241.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.7M | -78.2% |
| FY2024 | -$135.7M | -47.1% |
| FY2023 | -$92.2M | -36.3% |
| FY2022 | -$67.7M | -185.4% |
| FY2021 | -$23.7M | +32.1% |
| FY2020 | -$34.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VERA financial trends
VERA RevenueVERA Net incomeVERA Net marginVERA Gross profitVERA Gross marginVERA Operating incomeVERA Operating marginVERA Operating cash flowVERA Capital expendituresVERA Return on equityVERA Stock buybacksVERA Dividends paidVERA Total assetsVERA Total liabilitiesVERA Shareholders’ equityVERA overview →